(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $1029.56 | $1008.78 | $1087.85 | $939.79 |
Inventory | ||||
Total current assets | $3344.84 | $3404.74 | $3403.02 | $3464.55 |
Long term investments | ||||
Property, plant & equipment | $1247.86 | $1278.11 | $1386.03 | $1265.3 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $20777.92 | $21161.1 | $21512.74 | $21544.77 |
Current liabilities | ||||
Accounts payable | $541.43 | $531.3 | $608.86 | $587.61 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $5271.13 | $5509.38 | $2927.79 | $2796.95 |
Long term debt | $2904.27 | $2743.05 | $4955.4 | $4969.42 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $16553.09 | $16735.42 | $16850.67 | $16760.07 |
Shareholders' equity | ||||
Retained earnings | -$788.45 | -$505.36 | -$272.47 | -$117.06 |
Other shareholder equity | $13.28 | -$25.5 | -$20.54 | -$0.16 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $1190.33 | |||
Short term investments | ||||
Net receivables | $939.79 | $917 | $615.01 | $445.78 |
Inventory | ||||
Total current assets | $3464.55 | $2536.74 | $3753.75 | $2065.21 |
Long term investments | ||||
Property, plant & equipment | $1265.3 | $1042.85 | $1003.46 | $613.14 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $7568.43 | |||
Total investments | ||||
Total assets | $21544.77 | $12503.84 | $11434.52 | $9633.63 |
Current liabilities | ||||
Accounts payable | $587.61 | $600.61 | $558.86 | $554.26 |
Deferred revenue | $606.53 | |||
Short long term debt | ||||
Total current liabilities | $2796.95 | $2414.54 | $2705.44 | $1997.08 |
Long term debt | $4969.42 | $5080.24 | $5631.71 | $5712.83 |
Total noncurrent liabilities | $6672.58 | |||
Total debt | ||||
Total liabilities | $16760.07 | $10623 | $10187.47 | $8669.66 |
Shareholders' equity | ||||
Retained earnings | -$117.06 | -$216.22 | -$296.62 | |
Other shareholder equity | -$0.16 | -$23.74 | -$80.53 | $495.34 |
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1751.27 | $1850.28 | $1582.71 | |
Cost of revenue | ||||
Gross Profit | $1009.28 | $1005.67 | $937.28 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $897.81 | $1252.59 | $897.92 | |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | -$143.38 | -$111.83 | $13.93 | |
Interest expense | -$97.57 | -$102.44 | -$88.32 | |
Net income | ||||
Net income | -$214.52 | -$137.34 | $14.52 | |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $5960.16 | $5268.14 | $5077.71 | $3478.74 |
Cost of revenue | ||||
Gross Profit | $3518.54 | $3202.36 | $2480.53 | $1733.47 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $3124.07 | $2624.64 | $2498.25 | $1666.21 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $219.84 | -$648.5 | -$22.28 | $8.51 |
Interest expense | -$345.68 | -$302.25 | -$268.68 | -$284.59 |
Net income | ||||
Net income | $356.52 | $129.13 | -$296.63 | -$654.93 |
Income (for common shares) |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$199.75 | -$132.25 | -$72.25 | $730.44 |
Financing activities | ||||
Dividends paid | -$80.56 | -$54.23 | -$27.09 | -$125.18 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$354.01 | -$472.07 | -$131.54 | -$734.14 |
Effect of exchange rate | $2.74 | -$4.55 | -$3.9 | $4.99 |
Change in cash and equivalents | -$115.71 | -$344.02 | -$343.96 | $398.95 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $730.45 | -$704.53 | -$659.08 | -$315.79 |
Financing activities | ||||
Dividends paid | -$125.18 | -$36.39 | -$9.18 | -$123.17 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$734.16 | -$549.91 | $960.17 | $453.99 |
Effect of exchange rate | $5.04 | -$20.13 | -$3.25 | $4.84 |
Change in cash and equivalents | $398.99 | -$747.04 | $602.7 | $304.26 |
Market cap | $24.06B |
---|---|
Enterprise value | N/A |
Shares outstanding | 684.13M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.63 |
Quick ratio | N/A |